PRA Health Sciences (PRAH) Tops Q4 EPS by 5c

PRA Health Sciences (NASDAQ: PRAH) reported Q4 EPS of $0.35, $0.05 better than the analyst estimate of $0.30. Revenue for the quarter came in at $370 million versus the consensus estimate of $323.5 million.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat